Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Delivering complex care in low resource settings

Dr Shailesh Shrikhande - Tata Memorial Center, Mumbai, India

Delivering complex care in low resource settings ( Dr Shailesh Shrikhande - Tata Memorial Center, Mumbai, India )

Editor's Choice for September 2017

Prof Gordon McVie - Founding Editor, ecancer

Editor's Choice for September 2017 ( Prof Gordon McVie - Founding Editor, ecancer )

The microbiome revolution

Mr James Kinross - Imperial College London, London, UK

The microbiome revolution ( Mr James Kinross - Imperial College London, London, UK )

Bladder cancer's relationship with the urinary and gut microbiomes

Dr Jeremy Burton - Lawson Health Research Institute, London, Canada

Bladder cancer's relationship with the urinary and gut microbiomes ( Dr Jeremy Burton - Lawson Health Research Institute, London, Canada )

ESMO 2017 highlights on managing difficult to treat cancers

Prof Richard Finn, Prof Viktor Grünwald, Prof Arndt Vogel, Prof René Adam

ESMO 2017 highlights on managing difficult to treat cancers ( Prof Richard Finn, Prof Viktor Grünwald, Prof Arndt Vogel, Prof René Adam )

ESMO 2017 roundup with Dr Bishal Gyawali (1/2)

Dr Bishal Gyawali - Nagoya University, Nagoya, Japan

ESMO 2017 roundup with Dr Bishal Gyawali (1/2) ( Dr Bishal Gyawali - Nagoya University, Nagoya, Japan )

ESMO 2017 roundup with Dr Bishal Gyawali (2/2)

Dr Bishal Gyawali - Nagoya University, Nagoya, Japan

ESMO 2017 roundup with Dr Bishal Gyawali (2/2) ( Dr Bishal Gyawali - Nagoya University, Nagoya, Japan )

Pembrolizumab falls short of endpoints in KEYNOTE 40

Dr Ezra Cohen - UC San Diego Health, San Diego, USA

Pembrolizumab falls short of endpoints in KEYNOTE 40 ( Dr Ezra Cohen - UC San Diego Health, San Diego, USA )

ARIEL3: Rucaparib as maintenance therapy in recurrent ovarian cancer patients

Prof Jonathan Ledermann - University College London Hospitals, London, UK

ARIEL3: Rucaparib as maintenance therapy in recurrent ovarian cancer patients ( Prof Jonathan Ledermann - University College London Hospitals, London, UK )

Initial results of inhibitor combination against breast and gynaecologic cancers

Dr Shannon Westin - MD Anderson Cancer Center, Houston, Texas

Initial results of inhibitor combination against breast and gynaecologic cancers ( Dr Shannon Westin - MD Anderson Cancer Center, Houston, Texas )

Chemoradiation remains best treatment for locally advanced cervical cancer

Prof Sudeep Gupta - Tata Memorial Hospital, Mumbai, India

Chemoradiation remains best treatment for locally advanced cervical cancer ( Prof Sudeep Gupta - Tata Memorial Hospital, Mumbai, India )

LORELEI trial of letrozole and taselisib for ER positive breast cancer

Dr Cristina Saura - Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain

LORELEI trial of letrozole and taselisib for ER positive breast cancer ( Dr Cristina Saura - Vall d´Hebron Institute of Oncology (VHIO), Barcelona, Spain )

More from ecancer